Cysteinyl Leukotriene Receptor 1 (CYSLTR1) Antibody

Este producto es parte de CYSLTR - Cysteinyl Leukotriene Receptor
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cysteinyl Leukotriene Receptor 1 (CYSLTR1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx324344
tested applications
ELISA, WB, IF/ICC

Description

CYSLTR1 Antibody is a Rabbit Polyclonal against CYSLTR1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Cysteinyl Leukotriene Receptor 1 (CYSLTR1)
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/5000, WB: 1/500 - 1/2000, IF/ICC: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IF/ICC
Buffer
PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9Y271
Gene ID
10800
Alias
CYSLTR1,CYSLT1,CYSLT1R,CYSLTR,HMTMF81,HG55,LTD4,leukotriene D4 receptor
Background
Antibody anti-CYSLTR1
Status
RUO

Descripción

CYSLTR1 is a G protein-coupled receptor (GPCR) that binds cysteinyl leukotrienes (CysLTs), including leukotriene C4 (LTC4), leukotriene D4 (LTD4), and leukotriene E4 (LTE4). It is highly expressed in smooth muscle cells, mast cells, eosinophils, and airway epithelial cells. CYSLTR1 signaling plays a central role in allergic and inflammatory responses, particularly in asthma and allergic rhinitis, where it mediates bronchoconstriction, vascular permeability, and mucus production. Activation of CYSLTR1 triggers the phospholipase C (PLC) pathway, leading to calcium mobilization and smooth muscle contraction. CYSLTR1 is also implicated in chronic inflammatory diseases such as atopic dermatitis and cardiovascular disorders. Its overactivation exacerbates tissue damage, airway hyperresponsiveness, and immune cell recruitment. Leukotriene receptor antagonists (LTRAs), such as montelukast and zafirlukast, target CYSLTR1 and are used clinically to manage asthma and allergic inflammation by blocking cysteinyl leukotriene signaling. CYSLTR1 remains a critical therapeutic target for allergic and inflammatory diseases.

Related Products

EH2922

Human CYSLTR1 (Cysteinyl Leukotriene Receptor 1) ELISA Kit

Ver Producto
abx028326

Cysteinyl Leukotriene Receptor 1 (CYSLTR1) Antibody

The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, the protein encoded by this gene and CYSLTR2. This encoded receptor is a member of the superfamily of G protein-coupled receptors. Activation of this receptor by LTD4 results in contraction and proliferation of smooth muscle, oedema, eosinophil migration and damage to the mucus layer in the lung.

Ver Producto
abx151230

Human Cysteinyl Leukotriene Receptor 1 (CYSLTR1) ELISA Kit

Human Cysteinyl Leukotriene Receptor 1 (CYSLTR1) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Cysteinyl Leukotriene Receptor 1 concentrations in serum, plasma, tissue homogenates, cell lysates and other biological fluids.

Ver Producto